Company
Every investor coverage indicates participated in a round Goldman Sachs Australia raised.
Companies Goldman Sachs Australia acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Stephen Fitzgerald | Boss (former) | Startup Daily |
| Christian Johnston | Chair | Startup Daily (Sat 23 Mar 2024), Startup Daily (Tue 31 Jan 2023) |
Stories naming Goldman Sachs Australia. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Brandon BioCatalyst has named Peter Beattie its chair as Bill Ferris retires, with Andrew Nash joining the board and Ross King becoming deputy; manager Brandon Capital's newly raised $439 million fund was noted.
Breakthrough Victoria defends its spending and investment record against critics urging its abolition, pointing to portfolio companies, university partnerships and recent backing of startups including Aravax.
University of Melbourne's Tin Alley Ventures fund has raised $100 million toward a $200 million target, backed by the university, Breakthrough Victoria and local business figures, with a second close targeted for mid-2023.
Also @AuManufacturing
Clinical trials matching startup HealthMatch, founded by a UNSW medical student, has closed a $6 million Series A led by Square Peg Capital and Tempus Partners, with Paul Bassat joining its board and a Roche partnership announced.
Also SmartCompany